Clinical trial
Registry of Irreversible Electroporation for the Ablation of Prostate Cancer…
NCT02255890 · Clinical Research Office of the Endourological Society, Other · Unknown status
Key facts
| NCT number | NCT02255890 |
|---|---|
| Title | Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device |
| Official title | Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device; A Multi-Center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety. |
| Lead sponsor | Clinical Research Office of the Endourological Society, Other |
| Status | Unknown status |
| Study type | Observational [Patient Registry] |
| Conditions | Prostate Cancer |
| Enrollment | 361 |
| Start date | Nov 1, 2014 |
| Primary completion | Jun 1, 2020 |
| Completion | Apr 1, 2025 |
| First posted | Oct 3, 2014 |
| Last update posted | Dec 14, 2020 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: